Desarrollo y Pilotaje de una Estrategia de Implementación para una Intervención Breve de Consejería sobre Seguridad de Medios Letales Basada en Entrevistas Motivacionales en Entornos de Atención Primaria (CDA-2)
Desarrollo y Puesta a Prueba de una Estrategia de Implementación para una Intervención Breve de Consejería sobre Seguridad de Medios Letales Basada en Entrevistas Motivacionales en Entornos de Atención Primaria
Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury. Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms. However, no LMS counseling interventions have been tested within VA. Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Steve Martino, PhD
- Número de teléfono: 2468 (203) 932-5711
- Correo electrónico: Steve.Martino@va.gov
Copia de seguridad de contactos de estudio
- Nombre: Frances Aunon, PhD MS
- Número de teléfono: 7894 (203) 932-5711
- Correo electrónico: Frances.Aunon@va.gov
Ubicaciones de estudio
-
-
Connecticut
-
West Haven, Connecticut, Estados Unidos, 06516-2770
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contacto:
- Steve Martino, PhD
- Número de teléfono: 2468 (203) 932-5711
- Correo electrónico: Steve.Martino@va.gov
-
Contacto:
- Kimberly L Selander, MA
- Número de teléfono: (203) 932-5711
- Correo electrónico: Kimberly.Selander@va.gov
-
Investigador principal:
- Frances Aunon, PhD MS
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
For Veterans:
- Has access to a firearm
- Referred to Primary Care Mental Health Integration (PCMHI) care
For clinicians (delivering intervention):
- Deliver care in Primary Care Mental Health Integration (PCMHI)
- Trained in RAMP and study procedures
Exclusion Criteria:
For Veterans:
- Unable to consent due to cognitive impairment, severity of illness (including psychiatric symptoms), intoxication with drugs and/or alcohol
- Unreliable telephone access
- Inability to read English or communicate in spoken and written English
For clinicians (delivering intervention):
- Did not participate in training
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Comparador activo: Active control
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
|
Experimental: RAMP
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Screening
Periodo de tiempo: through study completion, approximately 2 years
|
Investigators will assess the number of new Primary Care Mental Health Integration (PCMHI) patients seen in PCMHI and the number who were approached about potential study participation per month |
through study completion, approximately 2 years
|
|
Recruitment
Periodo de tiempo: through study completion, approximately 2 years
|
Investigators will track the number of eligible Veterans who enrolled in the study per month |
through study completion, approximately 2 years
|
|
Retention
Periodo de tiempo: approximately 30 days
|
Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments. |
approximately 30 days
|
|
Assessment of behavioral outcomes
Periodo de tiempo: approximately 30 days
|
Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint |
approximately 30 days
|
|
Veteran acceptability - Theoretical Framework of Acceptability
Periodo de tiempo: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Veteran acceptability - Experience and Satisfaction with intervention
Periodo de tiempo: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Clinician acceptability - Theoretical Framework of Acceptability
Periodo de tiempo: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
|
Clinician acceptability - Negative impact
Periodo de tiempo: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will assess to what extent Primary Care Mental Health Integration (PCMHI) clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree." For those responding >3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration). |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Frances Aunon, PhD MS, VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- HSR4-001-24W
- 1IK2RD000503-01A2 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .